Shu-Chih Chen
Fondatore presso ATOSSA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Shu-Chih Chen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/04/2009 | - |
| Fondatore | 01/12/2008 | - | |
| Direttore Tecnico/Scientifico/R&S | 01/04/2010 | - |
Storia della carriera di Shu-Chih Chen
Precedenti posizioni note di Shu-Chih Chen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SC2Q Consulting Co. | Fondatore | 01/01/2006 | 01/01/2008 |
| Presidente | - | 01/01/2008 | |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Direttore/Membro del Consiglio | 01/01/2002 | 01/01/2006 |
| Ensisheim Partners LLC | Presidente | 01/01/2008 | - |
| National Yang Ming University | Corporate Officer/Principal | - | - |
Formazione di Shu-Chih Chen
| Michigan State University | Doctorate Degree |
| National Yang Ming University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Taiwan | 2 |
Posizioni
| Director/Board Member | 2 |
| Founder | 2 |
| President | 2 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| SC2Q Consulting Co. | |
| Ensisheim Partners LLC | |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
- Borsa valori
- Insiders
- Shu-Chih Chen
- Esperienza
